| Active substance |
Mirtazapine |
| Also known as |
Remeron |
| Blood pressure |
Can cause orthostatic hypotension |
| Chemical name |
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
| Dosage (medical) |
15-45 mg per day |
| Dosage (sports) |
Not applicable |
| Effects |
Antidepressant, anxiolytic, sedative |
| Formula |
C17H19N3 |
| Half-life |
20 to 40 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not specific |
| Main action |
Antidepressant, enhances central noradrenergic and serotonergic activity |
| Side effects |
Weight gain, sedation, dry mouth, increased appetite, dizziness |
| Storage conditions |
Store at room temperature, protect from light and moisture |
| Strength |
7.5mg |
| Substance class |
Tetracyclic antidepressant |
| Trade name |
Remeron, others |
| Use in sports |
None |
| Water Retention |
Minimal |
| Manufacturer |
Intas Pharmaceuticals Ltd. |
| Packing |
10 tabs/blister |
